Skip to main content

Table 8 Characteristics of the patients from the Pitié-Salpêtrière database

From: An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients

Treatment group

 

Age (median)

Karnofsky (median)

Surgery

(% B/P/C)

MGMTP methylated

P16 not deleted (n = 141)

     

RT alone

N = 47

57

80

8/27/65

55%

RT+CT

N = 94

55

80

13/24/63

46%

P16 deleted (n = 81)

     

RT alone

N = 32

57

80

15/25/60

53%

RT+CT

N = 49

57

80

10/27/63

53%

  1. Surgery (B/P/C): Percentage of Biopsy/Partial/Complete surgery; MGMTP methylated: percentage of patients with methylated MGMT; RT: radiotherapy; RT+CT: radiotherapy and adjuvant chemotherapy.